Home
/ enBio
/ Competitors

enBio Competitors and Similar CompaniesClear all

enBio's competitors and similar companies include Kaufman Hall, Vasomedical, Cincinnati Surgical and DocCheck.

	enBio enBio Corporation delivers comprehensive biomedical technology management services.	Kaufman Hall Kaufman Hall is a company that provides management consulting solutions for the healthcare and education sectors.	Vasomedical Global leader in non-invasive outpatient therapy for the treatment of diseases of the cardiovascular system.	Cincinnati Surgical Cincinnati Surgical provides surgical products such as specialty surgical blades, handles, scalpels, suture needles, and post mortem staplers.	DocCheck DocCheck operates B2B portal for medical professionals.
Founding Date	Founding Date 1999	Founding Date 2014	Founding Date 1994	Founding Date 1938	Founding Date 1990
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Business Products & Services Healthcare clinics hospitals management consulting medical devices property management	Tags Business Products & Services investment management management consulting	Tags Healthcare clinics hospitals medical devices	Tags Healthcare Manufacturing & Industrial clinics hospitals medical devices	Tags Business Products & Services Healthcare clinics hospitals management consulting market research platform
Locations	Locations Burbank, US HQ	Locations Chicago, US HQ Chicago, US El Segundo, US	Locations Plainview, US HQ New York, US	Locations Cincinnati, US HQ	Locations Köln, DE HQ
Employees	Employees 922% decrease	Employees 597	Employees 3173% increase	Employees 109% decrease	Employees 373
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 26.3 m	Valuation ($) N/A	Valuation ($) 51.3 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $89.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €55.3m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $34.4m (FY, 2025)	Cost of goods N/A	Cost of goods €18.2m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $54.7m (FY, 2025)	Gross profit N/A	Gross profit €37.9m (FY, 2025)